These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9612045)

  • 41. [The clinical effect and dynamics of hormonal homeostasis with the inclusion of plasmosorption in the combined therapy of patients with maxillofacial phlegmons against a background of diabetes mellitus].
    Pchelin VG; Zuev VP
    Stomatologiia (Mosk); 1994; 73(2):30-3. PubMed ID: 9612044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitamin E, atherosclerosis and thrombosis.
    Violi F; Micheletta F; Iuliano L
    Thromb Haemost; 2001 May; 85(5):766-70. PubMed ID: 11372665
    [No Abstract]   [Full Text] [Related]  

  • 43. [Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area].
    Khamitov FS; Faizov TT; Berim MG
    Stomatologiia (Mosk); 1985; 64(1):35-7. PubMed ID: 3857735
    [No Abstract]   [Full Text] [Related]  

  • 44. [The use of gastric juice in the complex therapy of phlegmons of the perimaxillary region].
    Magarill ESh; Protasevich AI; Koltun RK; Krivolutskaia EG; Inkarbekov ZhB
    Stomatologiia (Mosk); 1972; 51(3):43-5. PubMed ID: 4506904
    [No Abstract]   [Full Text] [Related]  

  • 45. [The role of alpha-tocopherol and retinol in correcting disorders of lipid peroxidation in patients with malignant liver neoplasms].
    Gorozhanskaia EG; Patiutko II; Sagaidak IV
    Vopr Onkol; 1995; 41(1):47-51. PubMed ID: 7667941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Stimulation of body resistance in the therapy of perimaxillary phlegmons].
    Robustova TG; Shalumov AS
    Stomatologiia (Mosk); 1979; 58(5):36-41. PubMed ID: 292176
    [No Abstract]   [Full Text] [Related]  

  • 47. Lipid peroxidation and the activity of some antioxidant enzymes in patients with systemic vasculitides treated with corticoids.
    Tănăseanu S; Serban MG; Niţă V
    Rom J Intern Med; 1994; 32(1):47-50. PubMed ID: 8081311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evaluation of chlorhexidine effectiveness in treating acute inflammatory processes of the maxillofacial region].
    Gapanenko TG; Pecherkina SA; Kislykh FI; Dudin AB
    Stomatologiia (Mosk); 1983; 62(1):41-3. PubMed ID: 6572436
    [No Abstract]   [Full Text] [Related]  

  • 49. [Use of miramistin for the treatment of patients with odontogenic phlegmons in the maxillofacial area].
    Bazhanov NN; Aleksandrov MT; Cherkesov IV
    Stomatologiia (Mosk); 2006; 85(3):24-6. PubMed ID: 16858318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The use of the preparation baliz-2 in inflammatory processes of the maxillofacial area].
    Bernadskaia GP; Timofeev AA; Kutsenko TA
    Stomatologiia (Mosk); 1989; 68(6):10-1. PubMed ID: 2623675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Blood amino acid composition in inflammatory diseases of the maxillofacial area].
    Shcherbatiuk DI; Anestiiadi MIa
    Stomatologiia (Mosk); 1980; 59(5):29-31. PubMed ID: 6932749
    [No Abstract]   [Full Text] [Related]  

  • 52. [Intensity of lipid peroxidation in the small intestinal wall in peritonitis and its correction].
    Diachuk IA; Benedikt VV
    Khirurgiia (Mosk); 1994 Mar; (3):22-4. PubMed ID: 8007607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A rational approach to antioxidant therapy and vitamin E.
    Hyman M; Pizzorno J; Weil A
    Altern Ther Health Med; 2005; 11(1):14-7. PubMed ID: 15712759
    [No Abstract]   [Full Text] [Related]  

  • 54. Selenium-vitamin E combination and melatonin modulates diabetes-induced blood oxidative damage and fetal outcomes in pregnant rats.
    Guney M; Erdemoglu E; Mungan T
    Biol Trace Elem Res; 2011 Nov; 143(2):1091-102. PubMed ID: 21240568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Changes in the blood osmotic state as affected by hyperbaric oxygenation in patients with acute inflammation of the maxillofacial area].
    Aleksandrov VN; Shpektor VA; Sredniakov VA; Maksimov BN; Markin SA
    Stomatologiia (Mosk); 1983; 62(4):43-5. PubMed ID: 6578619
    [No Abstract]   [Full Text] [Related]  

  • 56. [Significance of a spiramycin-metronidazole combination in the treatment of acute, circumscribed perimaxillary cellulitis].
    Feki A
    Chir Dent Fr; 1981 Dec; 51(136):49-51. PubMed ID: 6948670
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinicoimmunological effects of piracetam and aevit in the course of duodenal ulcer patients' therapy].
    Balobanov VI; Vakhrushev SP; Velikosel'skaia LM
    Klin Med (Mosk); 1996; 74(7):56-7. PubMed ID: 8992120
    [No Abstract]   [Full Text] [Related]  

  • 58. [The clinico-endoscopic, psychological and physical characteristics of duodenal peptic ulcer patients using piracetam and aevit].
    Pimenov LT; Balobanov VIu; Pushina LN; Shemiakina TV
    Ter Arkh; 1997; 69(2):10-3. PubMed ID: 9173565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The clinical value of determining erythrocyte sorption capacity and the levels of middle molecules and circulating immune complexes in assessing endotoxemia in patients with abscesses and phlegmons of the maxillofacial area].
    Karshiev KhK
    Stomatologiia (Mosk); 1998; 77(2):35-6. PubMed ID: 9584591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Enzyme therapy of patients with pyo-inflammatory disease of maxillofacial area].
    Minaev SV; Ibragimov OR; Zelenskiĭ VA; Minaeva NV
    Voen Med Zh; 2007 Nov; 328(11):25-7, 96. PubMed ID: 18306709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.